Clinical trial
Gene Therapy in Treating Patients With Cancer
NCT00004178 · Roger Williams Medical Center, Other · Completed
Key facts
| NCT number | NCT00004178 |
|---|---|
| Title | Gene Therapy in Treating Patients With Cancer |
| Official title | Phase I Study of T Cells Modified With Chimeric AntiCEA Immunoglobulin-T Cell Receptors (IgTCR) in Adenocarcinoma |
| Lead sponsor | Roger Williams Medical Center, Other |
| Collaborators | Beth Israel Deaconess Medical Center |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Biological |
| Interventions | therapeutic autologous lymphocytes |
| Start date | Apr 1, 1998 |
| Primary completion | Dec 1, 2000 |
| Completion | Dec 1, 2001 |
| First posted | Apr 19, 2004 |
| Last update posted | Jun 10, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: